Author

Ke Yao

Tsinghua UniversityORCID 0000-0003-2638-2978Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Ke Yao1 paper · Yuxi Normal University

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Bin YueiD· 1 shared Bingxin ZhengiD· 1 shared Haitian HuiD· 1 shared Hanqiu ZhengiD· 1 shared Huijuan FaniD· 1 shared Tengjiang ZhangiD· 1 shared Xuan LiiD· 1 shared Xuxiang WangiD· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Bin YueORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyCancer ResearchPeer-reviewedDec 1, 2023

Osteoclast-Cancer Cell Metabolic Symbiosis Renders PARP Inhibitor Therapy Resistance in Bone Metastasis

Huijuan Fan, Zhanao Xu, Ke Yao…·Hanqiu Zheng

This study identifies a metabolic symbiosis between osteoclasts and cancer cells in bone metastasis that contributes to PARP inhibitor resistance, showing that targeting this interaction with PARPi and zoledronate can synergistically reduce metastasis.

40 citationstop 3%

humanbulk RNA-seq

𝕏 PostBluesky